Cells penetrating molecules in living systems hold promise
of capturing
and eliminating threats and damage that can plan intracellular fate
promptly. However, it remains challenging to construct cell penetration
systems that are physiologically stable with predictable self-assembly
behavior and well-defined mechanisms. In this study, we develop a
core–shell nanoparticle using a hyaluronic acid (HA)-coated
protein transduction domain (PTD) derived from the human immunodeficiency
virus (HIV). This nanoparticle can encapsulate pathogens, transporting
the PTD into macrophages via lipid rafts. PTD forms hydrogen bonds
with the components of the membrane through TAT, which has a high
density of positive charges and reduces the degree of membrane order
through Tryptophan (Trp)-zipper binding to the acyl tails of phospholipid
molecules. HA-encapsulated PTD increases the resistance to trypsin
and proteinase K, thereby penetrating macrophages and eliminating
intracellular infections. Interestingly, the nonagglutination mechanism
of PTD against pathogens ensures the safe operation of the cellular
system. Importantly, PTD can activate the critical pathway of antiferroptosis
in macrophages against pathogen infection. The nanoparticles developed
in this study demonstrate safety and efficacy against Gram-negative
and Gram-positive pathogens in three animal models. Overall, this
work highlights the effectiveness of the PTD nanoparticle in encapsulating
pathogens and provides a paradigm for transduction systems-anti-intracellular
infection therapy.